药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Ceforanide
Triptorelin
The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Oxprenolol.
Ceforanide
Histrelin
The risk or severity of QTc prolongation can be increased when Histrelin is combined with Oxprenolol.
Ceforanide
Buserelin
The risk or severity of QTc prolongation can be increased when Buserelin is combined with Oxprenolol.
Ceforanide
Degarelix
The risk or severity of QTc prolongation can be increased when Degarelix is combined with Oxprenolol.
Ceforanide
Pasireotide
The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Oxprenolol.
Ceforanide
Tandutinib
The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Oxprenolol.
Ceforanide
Farnesyl thiopyrophosphate
The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Oxprenolol.
Ceforanide
Fleroxacin
The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Oxprenolol.
Ceforanide
Vorinostat
The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Oxprenolol.
Ceforanide
Pheniramine
The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Oxprenolol.
Ceforanide
Solifenacin
The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Oxprenolol.
Ceforanide
Cilostazol
The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Oxprenolol.
Ceforanide
Levocabastine
The risk or severity of QTc prolongation can be increased when Levocabastine is combined with Oxprenolol.
Ceforanide
Mequitazine
The risk or severity of QTc prolongation can be increased when Mequitazine is combined with Oxprenolol.
Ceforanide
Gatifloxacin
The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Oxprenolol.
Ceforanide
Tolterodine
The risk or severity of QTc prolongation can be increased when Tolterodine is combined with Oxprenolol.
Ceforanide
Emedastine
The risk or severity of QTc prolongation can be increased when Emedastine is combined with Oxprenolol.
Ceforanide
Ivosidenib
The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Ivosidenib.
Ceforanide
Dexchlorpheniramine
The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Dexchlorpheniramine.
Ceforanide
Sitafloxacin
The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Sitafloxacin.